BLOOMFIELD HILLS, MI--(Marketwired - Dec 3, 2013) - Health Enhancement Products, Inc. (
The corporate website, www.health-enhancement-products.com, now features, among other upgrades and expansions, a Project Updates section for timely communications on events and research progress that don't necessarily justify a wide-release announcement but may well be of interest to a select audience.
The newly-created WellMetris website, www.wellmetris.com, features a new video that describes the wellness assessment system offered to employers, insurers, accountable care organizations and governments for pre-clinical screening of at-risk individuals in largely asymptomatic groups. The site also features a Project Updates section that Company principals anticipate will be refreshed on a periodic basis.
"The Project Updates feature allows us to keep shareholders and other interested parties informed of ongoing work and developments without overemphasizing any individual step in the process," states Company President and CEO Andrew Dahl. "Significant events will always be announced via wide-distribution press releases, SEC filings and public forums, but much of the forward progress on the scientific front can be more appropriately handled on the websites. We've also activated the Twitter feature, which we intend to update on a regular basis, as well."
The shift in communication policy reflects the recent completion of various validation and development experiments that can now be filed as provisional patents or as continuations of existing patents and applications.
About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. is a health and wellness company engaged in the development of algae-derived, natural products for use as dietary supplements and food ingredients. The Company has developed a portfolio of natural, bioactive compounds wholly owned by Health Enhancement Products and protected by patents, patents pending, and trade secrets, to be licensed to manufacturers. These natural products are extracted from living algae grown in purified water.
Safe Harbor Statement
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the timing of completion of a trial, actual future clinical trial results being different than the results the company has obtained to date, and the company's ability to secure funding. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and those actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.